Presseportal.de - Pivotal Therapeutics Inchttp://www.presseportal.de/pm/106292/pivotal-therapeutics-inc/rssPresseportal.de: Pivotal Therapeutics Inc (Digitale Pressemappe)de-denews aktuell GmbHhttp://www.presseportal.de/images/logo_napresseportal.gifPresseportal.de - Pivotal Therapeutics Inchttp://www.presseportal.de/pm/106292/pivotal-therapeutics-inc/rssredaktion@presseportal.de (presseportal.de)Wed, 22 May 2013 04:05:44 +0200Tue, 07 May 2013 17:55:03 +02006Pivotal Therapeutics VASCAZEN®-REVEAL Trial Meets Primary and Secondary Endpoints - VASCAZEN® Shows 121% Correction of an Omega-3 Deficiency (p< 0.0001) with a Concomittant 48% Reduction in Triglycerides (p<0.0005)Pivotal Therapeutics Inc: Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, presented positive, statistically ...http://www.presseportal.de/pm/106292/2467259/pivotal-therapeutics-vascazen-reveal-trial-meets-primary-and-secondary-endpoints-vascazen-shows-121/rssTue, 07 May 2013 17:55:03 +0200http://www.presseportal.de/pm/106292/2467259/pivotal-therapeutics-vascazen-reveal-trial-meets-primary-and-secondary-endpoints-vascazen-shows-121/rss Pivotal Therapeutics Inc [Pressemappe]
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, presented positive, statistically ... Lesen Sie hier weiter...
]]>Wirtschaftredaktion@presseportal.de (presseportal.de)Excelitas TechnologiesPivotal's Founder and Chairman Dr. George Jackowski receives Queen Elizabeth II Diamond Jubilee MedalPivotal Therapeutics Inc: Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that Dr. ...http://www.presseportal.de/pm/106292/2463732/pivotal-s-founder-and-chairman-dr-george-jackowski-receives-queen-elizabeth-ii-diamond-jubilee-medal/rssThu, 02 May 2013 18:40:36 +0200http://www.presseportal.de/pm/106292/2463732/pivotal-s-founder-and-chairman-dr-george-jackowski-receives-queen-elizabeth-ii-diamond-jubilee-medal/rss Pivotal Therapeutics Inc [Pressemappe]
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that Dr. ... Lesen Sie hier weiter...
]]>Wirtschaftredaktion@presseportal.de (presseportal.de)Excelitas TechnologiesPivotal Therapeutics Inc. Generates Positive Feedback at European Society of Cardiology Congress 2012Pivotal Therapeutics Inc: Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to announce that the company received a positive ...http://www.presseportal.de/pm/106292/2319318/pivotal-therapeutics-inc-generates-positive-feedback-at-european-society-of-cardiology-congress-2012/rssTue, 04 Sep 2012 19:33:24 +0200http://www.presseportal.de/pm/106292/2319318/pivotal-therapeutics-inc-generates-positive-feedback-at-european-society-of-cardiology-congress-2012/rss Pivotal Therapeutics Inc [Pressemappe]
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to announce that the company received a positive ... Lesen Sie hier weiter...
]]>Wirtschaftredaktion@presseportal.de (presseportal.de)Excelitas TechnologiesPivotal Therapeutics Exhibiting at European Society of Cardiology Congress 2012Pivotal Therapeutics Inc: Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to announce that the company will be exhibiting at ...http://www.presseportal.de/pm/106292/2312223/pivotal-therapeutics-exhibiting-at-european-society-of-cardiology-congress-2012/rssThu, 23 Aug 2012 21:07:04 +0200http://www.presseportal.de/pm/106292/2312223/pivotal-therapeutics-exhibiting-at-european-society-of-cardiology-congress-2012/rss Pivotal Therapeutics Inc [Pressemappe]
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to announce that the company will be exhibiting at ... Lesen Sie hier weiter...
]]>Wirtschaftredaktion@presseportal.de (presseportal.de)Excelitas TechnologiesPivotal Announces Scientific Presentation at the 17th World Congress on Heart Disease Demonstrating Superiority of VASCAZEN? Unique FormulationPivotal Therapeutics Inc: Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CNSX:PVO), a specialty pharmaceutical company with a focus on cardiovascular health, is pleased to announce that data from a scientific study related to the company's ...http://www.presseportal.de/pm/106292/2304125/pivotal-announces-scientific-presentation-at-the-17th-world-congress-on-heart-disease-demonstrating/rssThu, 09 Aug 2012 22:47:44 +0200http://www.presseportal.de/pm/106292/2304125/pivotal-announces-scientific-presentation-at-the-17th-world-congress-on-heart-disease-demonstrating/rss Pivotal Therapeutics Inc [Pressemappe]
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CNSX:PVO), a specialty pharmaceutical company with a focus on cardiovascular health, is pleased to announce that data from a scientific study related to the company's ... Lesen Sie hier weiter...
]]>Wirtschaftredaktion@presseportal.de (presseportal.de)Excelitas Technologies